Brain-therapy innovation gets spotlight in this piece exploring a venture-creation approach designed to bridge translational hurdles and accelerate treatments reaching patients.
Key Takeaways
- Deep Science Ventures and Medicines Discovery Catapult will jointly review brain drug delivery gaps
- Findings will be used to create new startups supported by pre-seed funding
- DSV highlighted the blood–brain barrier and said over 40% are affected by neurological conditions